Abstract
There is an increasing need for predictors of clinical outcomes in patients with ulcerative colitis (UC). In this exploratory analysis, we aimed to analyze
Funding Information
  • Takeda Pharmaceutical Company

This publication has 44 references indexed in Scilit: